title: [First-line therapy for "high-risk prostate cancer". HELP - high intensity focused ultrasound (HIFU) and Eilgard in patients with high-risk prostate cancer - a prospective, randomized study (AP 62/10 of the AUO)].
authors.affiliation: Geschäftsstelle der AUO, MeckEvidence, Seestraße 11, 17252, Schwarz, Deutschland, AUO@MeckEvidence.de.
authors.forename: H
authors.initials: H
authors.lastname: Rexer
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D003131:Combined Modality Therapy / Q000379:methods; D005858:Germany; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D018570:Risk Assessment; D016896:Treatment Outcome; D036761:Ultrasound, High-Intensity Focused, Transrectal / Q000379:methods*
chemical_list: D018931:Antineoplastic Agents, Hormonal; C493311:luprolide acetate gel depot; D016729:Leuprolide